BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 15349816)

  • 1. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.
    Folgueras AR; Pendás AM; Sánchez LM; López-Otín C
    Int J Dev Biol; 2004; 48(5-6):411-24. PubMed ID: 15349816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
    Zucker S; Cao J; Chen WT
    Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The other side of MMPs: protective roles in tumor progression.
    Martin MD; Matrisian LM
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):717-24. PubMed ID: 17717634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
    Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach.
    Bachmeier BE; Iancu CM; Jochum M; Nerlich AG
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):149-63. PubMed ID: 15757447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for MMP inhibition in cancer: innovations for the post-trial era.
    Overall CM; López-Otín C
    Nat Rev Cancer; 2002 Sep; 2(9):657-72. PubMed ID: 12209155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.
    Jodele S; Blavier L; Yoon JM; DeClerck YA
    Cancer Metastasis Rev; 2006 Mar; 25(1):35-43. PubMed ID: 16680570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases in tumour invasion and metastasis.
    Curran S; Murray GI
    J Pathol; 1999 Nov; 189(3):300-8. PubMed ID: 10547590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.
    Klein G; Vellenga E; Fraaije MW; Kamps WA; de Bont ES
    Crit Rev Oncol Hematol; 2004 May; 50(2):87-100. PubMed ID: 15157658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
    Hamacher S; Matern S; Roeb E
    Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and cancer.
    Cox G; O'Byrne KJ
    Anticancer Res; 2001; 21(6B):4207-19. PubMed ID: 11908674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model.
    Arlt M; Kopitz C; Pennington C; Watson KL; Krell HW; Bode W; Gansbacher B; Khokha R; Edwards DR; Krüger A
    Cancer Res; 2002 Oct; 62(19):5543-50. PubMed ID: 12359766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
    Masson V
    Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity and clinical implications of the matrix metalloproteinases.
    Rydlova M; Holubec L; Ludvikova M; Kalfert D; Franekova J; Povysil C; Ludvikova M
    Anticancer Res; 2008; 28(2B):1389-97. PubMed ID: 18505085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases and bladder cancer.
    Kanayama H
    J Med Invest; 2001 Feb; 48(1-2):31-43. PubMed ID: 11286015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix remodelling: the role of matrix metalloproteinases.
    Stamenkovic I
    J Pathol; 2003 Jul; 200(4):448-64. PubMed ID: 12845612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting.
    Gialeli C; Theocharis AD; Karamanos NK
    FEBS J; 2011 Jan; 278(1):16-27. PubMed ID: 21087457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pericellular proteases in angiogenesis and vasculogenesis.
    van Hinsbergh VW; Engelse MA; Quax PH
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):716-28. PubMed ID: 16469948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and tumor progression.
    Freije JM; Balbín M; Pendás AM; Sánchez LM; Puente XS; López-Otín C
    Adv Exp Med Biol; 2003; 532():91-107. PubMed ID: 12908552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biological role and regulation of matrix metalloproteinases (MMP) in cancer.
    Davidson B; Reich R; Risberg B; Nesland JM
    Arkh Patol; 2002; 64(3):47-53. PubMed ID: 15338725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.